Health

Results: 385-396 of 4415

PR Newswire associated0

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU® (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Business Wire logo

Sudden Hearing Loss Study Reaches Milestone: AudioCure Pharma Enrolls More Than Half of the Patients in AC102 Study

New protections for whistleblowers under NHS manager proposals

ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights

Business Wire logo

Exact Sciences Advances Breast Cancer Care with the Oncotype DX® test and Genomic Profiling Research at SABCS 2024

PR Newswire associated0

Alkermes to Participate in Upcoming Investor Conferences

PR Newswire associated0

International Conference on Conjoined Twins in Riyadh Closes with Call to Action, Millions Announced in New Humanitarian Aid Initiatives

Business Wire logo

Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting

PR Newswire associated0

Haier Named Official Partner of the Australian Open for 2025-2027

HemoHIM G, produced by Kolmar BNH and distributed by Atomy (Photo: Kolmar BNH)

Kolmar BNH Revolutionizes ESG with HemoHIM, an Eco-friendly Health Supplement

PR Newswire associated0

Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline

PR Newswire associated0

LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System